Skip to main content

Table 2 Injection protocol of BTX-A

From: Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review

Author

Source of BTX-A

Amount of BTX-A (U)

Injection sites

No. of injections

Wu et al. [56]

Lanzhou Biological Products Institute, China

75

Intradermal and/or submucosal trigger zones

15

Bohluli et al. [57]

Unclear

50

Trigger zones

Unclear

Zúñiga et al. [58]

Botox

20-50

Subdermal trigger zones

Unclear

Türk et al. [59]

Botox

100

Region of the zygomatic arch

2

Piovesan et al. [51]

Unclear

6-9

Subdermal trigger zones

Varied for each patient

Borodic et al. [60]

Botox

30-50

Subdermal trigger zones

Unclear